vs

Side-by-side financial comparison of iQSTEL Inc (IQST) and Schrodinger, Inc. (SDGR). Click either name above to swap in a different company.

Schrodinger, Inc. is the larger business by last-quarter revenue ($87.2M vs $84.2M, roughly 1.0× iQSTEL Inc). Schrodinger, Inc. runs the higher net margin — 37.3% vs -3.2%, a 40.5% gap on every dollar of revenue. On growth, Schrodinger, Inc. posted the faster year-over-year revenue change (-1.2% vs -14.9%). iQSTEL Inc produced more free cash flow last quarter ($-1.2M vs $-16.1M). Over the past eight quarters, Schrodinger, Inc.'s revenue compounded faster (54.4% CAGR vs 28.0%).

iQSTEL Inc is a technology holding company operating three core segments: telecommunications, Internet of Things (IoT), and fintech. It offers connectivity services, smart IoT monitoring solutions, and digital financial tools, mainly serving small and medium-sized enterprises and retail customers in North and South American markets.

Schrodinger, Inc. is a leading provider of advanced computational chemistry and physics software platforms, along with related consulting services, focused on accelerating drug discovery and novel materials development. Its solutions are adopted by biopharmaceutical companies, chemical manufacturers, academic research institutions and government entities across North America, Europe and Asia Pacific to cut R&D costs and shorten innovation cycles.

IQST vs SDGR — Head-to-Head

Bigger by revenue
SDGR
SDGR
1.0× larger
SDGR
$87.2M
$84.2M
IQST
Growing faster (revenue YoY)
SDGR
SDGR
+13.6% gap
SDGR
-1.2%
-14.9%
IQST
Higher net margin
SDGR
SDGR
40.5% more per $
SDGR
37.3%
-3.2%
IQST
More free cash flow
IQST
IQST
$14.9M more FCF
IQST
$-1.2M
$-16.1M
SDGR
Faster 2-yr revenue CAGR
SDGR
SDGR
Annualised
SDGR
54.4%
28.0%
IQST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IQST
IQST
SDGR
SDGR
Revenue
$84.2M
$87.2M
Net Profit
$-2.7M
$32.5M
Gross Margin
3.5%
65.7%
Operating Margin
-2.9%
-19.7%
Net Margin
-3.2%
37.3%
Revenue YoY
-14.9%
-1.2%
Net Profit YoY
-44.5%
180.8%
EPS (diluted)
$-0.92
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IQST
IQST
SDGR
SDGR
Q4 25
$84.2M
$87.2M
Q3 25
$102.9M
$54.3M
Q2 25
$72.2M
$54.8M
Q1 25
$57.6M
$59.6M
Q4 24
$98.9M
$88.3M
Q3 24
$54.2M
$35.3M
Q2 24
$78.6M
$47.3M
Q1 24
$51.4M
$36.6M
Net Profit
IQST
IQST
SDGR
SDGR
Q4 25
$-2.7M
$32.5M
Q3 25
$-2.3M
$-32.8M
Q2 25
$-2.3M
$-43.2M
Q1 25
$-1.1M
$-59.8M
Q4 24
$-1.9M
$-40.2M
Q3 24
$-773.0K
$-38.1M
Q2 24
$-2.0M
$-54.0M
Q1 24
$-580.2K
$-54.7M
Gross Margin
IQST
IQST
SDGR
SDGR
Q4 25
3.5%
65.7%
Q3 25
2.7%
51.6%
Q2 25
2.6%
47.8%
Q1 25
3.4%
52.3%
Q4 24
2.7%
72.6%
Q3 24
3.7%
50.2%
Q2 24
2.8%
66.2%
Q1 24
2.7%
51.6%
Operating Margin
IQST
IQST
SDGR
SDGR
Q4 25
-2.9%
-19.7%
Q3 25
-0.5%
-84.6%
Q2 25
-0.9%
-96.6%
Q1 25
-1.0%
-85.5%
Q4 24
-0.3%
-23.5%
Q3 24
-0.1%
-193.9%
Q2 24
-0.4%
-111.4%
Q1 24
-0.4%
-184.3%
Net Margin
IQST
IQST
SDGR
SDGR
Q4 25
-3.2%
37.3%
Q3 25
-2.3%
-60.4%
Q2 25
-3.3%
-78.8%
Q1 25
-2.0%
-100.4%
Q4 24
-1.9%
-45.5%
Q3 24
-1.4%
-108.1%
Q2 24
-2.5%
-114.2%
Q1 24
-1.1%
-149.5%
EPS (diluted)
IQST
IQST
SDGR
SDGR
Q4 25
$-0.92
$0.45
Q3 25
$-0.68
$-0.45
Q2 25
$-0.82
$-0.59
Q1 25
$-0.44
$-0.82
Q4 24
$-1.19
$-0.55
Q3 24
$-0.40
$-0.52
Q2 24
$-0.90
$-0.74
Q1 24
$-0.37
$-0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IQST
IQST
SDGR
SDGR
Cash + ST InvestmentsLiquidity on hand
$2.2M
$395.5M
Total DebtLower is stronger
$4.1M
Stockholders' EquityBook value
$16.3M
$364.1M
Total Assets
$51.1M
$726.2M
Debt / EquityLower = less leverage
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IQST
IQST
SDGR
SDGR
Q4 25
$2.2M
$395.5M
Q3 25
$2.3M
$391.2M
Q2 25
$2.0M
$450.2M
Q1 25
$1.1M
$500.3M
Q4 24
$2.5M
$352.1M
Q3 24
$2.1M
$388.7M
Q2 24
$797.2K
$377.3M
Q1 24
$2.7M
$431.1M
Total Debt
IQST
IQST
SDGR
SDGR
Q4 25
$4.1M
Q3 25
$2.7M
Q2 25
$4.5M
Q1 25
$3.5M
Q4 24
$2.5M
Q3 24
$3.2M
Q2 24
$2.5M
Q1 24
$194.0K
Stockholders' Equity
IQST
IQST
SDGR
SDGR
Q4 25
$16.3M
$364.1M
Q3 25
$17.9M
$321.4M
Q2 25
$14.3M
$342.9M
Q1 25
$11.6M
$373.5M
Q4 24
$11.9M
$421.4M
Q3 24
$8.1M
$449.4M
Q2 24
$7.6M
$474.0M
Q1 24
$8.4M
$513.7M
Total Assets
IQST
IQST
SDGR
SDGR
Q4 25
$51.1M
$726.2M
Q3 25
$46.9M
$653.7M
Q2 25
$51.4M
$688.2M
Q1 25
$42.0M
$743.0M
Q4 24
$79.0M
$823.2M
Q3 24
$32.4M
$669.3M
Q2 24
$30.0M
$688.4M
Q1 24
$22.1M
$737.8M
Debt / Equity
IQST
IQST
SDGR
SDGR
Q4 25
0.25×
Q3 25
0.15×
Q2 25
0.31×
Q1 25
0.31×
Q4 24
0.21×
Q3 24
0.40×
Q2 24
0.34×
Q1 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IQST
IQST
SDGR
SDGR
Operating Cash FlowLast quarter
$-1.2M
$-16.1M
Free Cash FlowOCF − Capex
$-1.2M
$-16.1M
FCF MarginFCF / Revenue
-1.5%
-18.5%
Capex IntensityCapex / Revenue
0.0%
0.0%
Cash ConversionOCF / Net Profit
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$-4.0M
$12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IQST
IQST
SDGR
SDGR
Q4 25
$-1.2M
$-16.1M
Q3 25
$-953.0K
$-61.9M
Q2 25
$257.7K
$-52.2M
Q1 25
$-1.9M
$144.1M
Q4 24
$-403.7K
$-31.1M
Q3 24
$625.0K
$-33.3M
Q2 24
$-2.6M
$-53.7M
Q1 24
$-536.9K
$-39.3M
Free Cash Flow
IQST
IQST
SDGR
SDGR
Q4 25
$-1.2M
$-16.1M
Q3 25
$-969.2K
$-62.4M
Q2 25
$211.7K
$-52.5M
Q1 25
$-2.0M
$143.5M
Q4 24
$-421.3K
$-32.0M
Q3 24
$594.5K
$-34.6M
Q2 24
$-2.6M
$-54.7M
Q1 24
$-608.5K
$-43.4M
FCF Margin
IQST
IQST
SDGR
SDGR
Q4 25
-1.5%
-18.5%
Q3 25
-0.9%
-114.8%
Q2 25
0.3%
-95.9%
Q1 25
-3.4%
240.9%
Q4 24
-0.4%
-36.2%
Q3 24
1.1%
-98.0%
Q2 24
-3.4%
-115.6%
Q1 24
-1.2%
-118.5%
Capex Intensity
IQST
IQST
SDGR
SDGR
Q4 25
0.0%
0.0%
Q3 25
0.0%
0.9%
Q2 25
0.1%
0.6%
Q1 25
0.1%
1.0%
Q4 24
0.0%
1.0%
Q3 24
0.1%
3.8%
Q2 24
0.0%
2.1%
Q1 24
0.1%
11.2%
Cash Conversion
IQST
IQST
SDGR
SDGR
Q4 25
-0.50×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IQST
IQST

USA$53.2M63%
Other$29.9M35%
Switzerland$1.1M1%

SDGR
SDGR

On Premise Software$44.4M51%
Drug Discovery Services$17.6M20%
Hosted Software$11.5M13%
Maintenance$6.9M8%
Professional Services$3.8M4%
July2024Agreement With Bill Melinda Gates Foundation$2.7M3%

Related Comparisons